This diabetes drug can protect against heart disease and control cholesterol, know more

An experimental diabetes drug called IC7Fc may help lower cholesterol and inflammation, two major drivers of heart disease. Here’s what researchers found

• Drug IC7Fc lowers cholesterol and inflammation in preclinical studies
• IC7Fc may benefit both obese and lean individuals at risk for heart disease
• Human trials are needed to confirm IC7Fc's effectiveness and safety

Did our AI summary help?

Heart disease has a habit of stealing the spotlight for all the wrong reasons. It remains the world’s biggest killer, despite decades of cholesterol-lowering drugs, blood pressure tablets and well-meaning advice about diet and exercise. Now, a drug once designed for diabetes is offering an intriguing new angle, and it could change how you think about treating cardiovascular risk.

Scientists have discovered that IC7Fc, an experimental drug previously linked to better blood sugar control, also tackles two of heart disease’s most stubborn drivers;  cholesterol and inflammation. In preclinical studies, the drug lowered levels of triglycerides and cholesterol while slowing the build-up of fatty plaques inside arteries. These plaques, which narrow and stiffen blood vessels, are the silent architects behind most heart attacks and strokes.

Also Read: Diabetes-friendly 2026: Nutritionist suggests smart diet tips, best exercises and healthy habits that last

The international research team, led by Leiden University Medical Centre and working closely with Monash University, tested the drug in mice genetically prone to heart disease. What stood out was not just the drop in blood fats, but the calming of inflammation inside blood vessels, a process increasingly recognised as a key trigger for cardiovascular events. Professor Mark Febbraio from Monash described the findings as a meaningful step forward, particularly given how many patients remain at risk despite standard treatments.

Weight loss and more

One of the most surprising elements of the study was what didn’t happen. In lean mice, IC7Fc did not reduce appetite or body weight, unlike earlier studies in obese mice, where weight loss was a clear effect. Yet the heart benefits remained.

This suggests the drug may work in two various ways

• helping reduce body fat in people with obesity
• protecting arteries in people who are not overweight but still face high cardiovascular risk

That distinction matters. Many people with heart disease do not fit the stereotype of being visibly overweight, yet they carry dangerous cholesterol levels and underlying inflammation.

Here’s what the drug appears to do

• lowers “bad” blood fats like triglycerides
• reduces cholesterol linked to artery damage
• slows plaque build-up inside blood vessels
• dampens inflammation that drives heart attacks and strokes

Also Read: Control diabetes and hypertension to keep brain healthy with these neurologist-approved tips

While the results are still confined to animal studies, the implications are hard to ignore. A single therapy that can target metabolic disease in some patients and heart disease in others would be a rare and valuable tool. Researchers stress that human trials are the next crucial step, but for now, IC7Fc offers hope in the fight against heart disease.

FAQs on Diabetes Drug, Heart Health, and Cholesterol Control

Can diabetes drugs help with heart health?

Some diabetes drugs, like IC7Fc, have shown potential in improving heart health by lowering triglycerides and cholesterol levels and reducing inflammation in the arteries.

How does IC7Fc affect cholesterol?

IC7Fc has been found to reduce levels of triglycerides and cholesterol, which are key factors in the development of heart disease.

Does IC7Fc help with weight loss?

IC7Fc promoted weight loss in obese mice but did not reduce appetite or body weight in lean mice, suggesting it may benefit both overweight individuals and those at high cardiovascular risk without affecting their weight.

What are the next steps for IC7Fc in treating heart disease?

The next crucial step is to conduct human trials to determine the drug’s efficacy and safety in treating heart disease in humans.

Disclaimer: This article, including health and fitness advice, only provides generic information. Don’t treat it as a substitute for qualified medical opinion. Always consult a specialist for specific health diagnosis.